Kennedy Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Kennedy Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-53,481	Closed	-$2.83M	–	724
2020 Q3	$2.83M	Buy	53,481 +7,024	+15%	+$434K	0.08%	428
2020 Q2	$2.85M	Buy	+46,457	New	+$2.69M	0.08%	436

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Kennedy Capital Management's BSTC Position: Q4 2020 in Review

Kennedy Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 53,481 shares — an estimated $2.83M sold.

Kennedy Capital Management first reported a position in BSTC in Q2 2020 and held it in 2 quarters. The position peaked at $2.85M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Kennedy Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Kennedy Capital Management sold 53,481 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $2.83M.
Kennedy Capital Management first reported a position in BioSpecifics Technologies Corp. in Q2 2020 and held it in 2 quarters.
Kennedy Capital Management's BioSpecifics Technologies Corp. position peaked at $2.85M in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Kennedy Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.